Common Causes of Short Stature Detectable by a Height Surveillance Programme

Vimpani GV Vimpani AF Lidgard GP Prevalence of severe growth hormone deficiency. BMJ 1977;ii:427–30.

Lindsay R Feldkamp M Harris D Robertson J Rallison M. Utah growth study: Growth standards and the prevalence of growth hormone deficiency. J Pediatr 1994;125:29–35.

Albertsson-Wikland K Wilton P Ranke MB. Growth hormone deficiency: Relationship to parental size and mode of birth. In: Ranke MB Gunnarsson R , eds. Progress in growth hormone therapy – 5 years of KIGS. Mannheim: J & J-Verlag, 1994:77–87.

Herber SM Milner RDG. When are we diagnosing growth hormone deficiency? Arch Dis Child 1986;61:110–12.

Price AP Ranke MB. Final height following growth hormone treatment. In: Ranke MB Gunnarsson R , eds. Progress in growth hormone therapy – 5 years of KIGS. Mannheim: J & J-Verlag, 1994:129–4.

August GP Lippe BM Blethen SL Growth hormone treatment in the United States: Demographic and diagnostic features of 2331 children. J Pediatr 1990;116:899–903.

Evans HJ. Chromosome anomalies among live births. J Med Genet 1977;14:309–12.

Brook CGD Murset G Zachmann M Prader A. Growth in children with 45,XO Turner's syndrome. Arch Dis Child 1974;49:789–95.

Rochiccioli P David M Malpeuch G Colle M Limal JM Battin J. Study of final heights in Turner's syndrome: Ethnic and genetic influences. Acta Paediatr 1994;83:305–8.

Karlberg J Albertsson-Wikland K Nilsson KO Ritzen EM Westphal O. Growth in infancy and childhood in girls with Turner's syndrome. Acta Paediatr Scand 1991;80:1158–65.

Lyon A Preece M Grant D. Growth curve for girls with Turner syndrome. Arch Dis Child 1985;60:932–5.

Ranke MB Pfluger H Rosendahl W Turner syndrome: Spontaneous growth in 150 cases and review of literature. EurJPediatr 1983;141:81–8.

Bernasconi S Larizza D Benso L Turner's syndrome in Italy: Familial characteristics, neonatal data, standards for birth weight and for height and weight from infancy to adulthood. Acta Paediatr 1994;83:292–8.

Rosenfeld RG Frane J Artie KM Six-year results of a randomised, prospective trial of human growth hormone and oxandrolone in Turner syndrome. J Pediatr 1992;121:49–55.

Witt DR Keena BA Hall JG Allanson JE. Growth curves for height in Noonan syndrome. Clin Genet 1986;30:150–3.

Allanson JE Hall JG Hughes HE Preus M Witt DR Noonan syndrome: The changing phenotype. Am J Med Genet 1985;2:507–14.

Ranke MB Heidemann P Knupfer C Enders H Schmaltz AA Bierich JR. Noonan syndrome: Growth and clinical manifestations in 144 cases. EurJPediatr 1988;148:220–7.

Sharland M Burch M McKenna WM Patton MA. A clinical study of Noonan syndrome. Arch Dis Child 1992; 67:178–83.

Nora JJ Nora AH Sinha AK Spangler RD Lubs HA. The UUrich-Noonan syndrome (Turner phenotype). Am J Dis Child 1974;127:48–55.

Cotterill AM McKenna WJ Elsawi M The effect of GH (Saizen) therapy (28 IU/m2/week) on linear growth and cardiac morphology in short children with Noonan syndrome. Pediatr Res 1993;33(suppl 5):S43.

Sung I Vohr BR Oh W. Growth and neurodevelopmental outcome of very low birthweight infants with intrauterine growth retardation: Comparison with control subjects matched by birth weight and gestational age. J Pediatr 1993;123:618–24.

Fitzhardinge PM Steven EM. The small-for-date infant, later growth patterns. Pediatrics 1972;49:671–81.

Fitzhardinge PM Inwood S. Long term growth in small-for-date children. Acta Paediatr Scand Suppl 1989;349:27–33.

Walther FJ Ramaekers LHJ. Growth in early childhood of newborns affected by disproportionate intra-uterine growth retardation. Acta Paediatr Scand 1982;71:651–6.

Thieriot-Prevost G Boccara JF Francoual C Badoual J Job JC. Serum insulin-like growth factor and serum growth-promoting activity during the first postnatal year in infants with intrauterine growth retardation. Pediatr Res 1988;24:380–3.

Barros FC Huttly SRA Victora CG Kirkwood BR Vaughan JP. Comparison of the causes and consequences of prematurity and intrauterine growth retardation: A longitudinal study in southern Brazil. Pediatrics 1992;90: 238–14.

Ross GJ Lipper EG Auld PAM. Growth achievement of very low birth weight premature children at school age. J Pediatr 1990;117:307–9.

Kitchen WH Ford GW Doyle LW. Growth and very low birth weight. Arch Dis ChUd 1989;64:379–82.

Villar J Smeriglio V Martorell R Brown CH Klein RE. Heterogeneous growth and mental development of intrauterine growth retarded infants during the first 3 years of life. Pediatrics 1984;74:783–91.

Chatelain PG Job JC Blanchard J Dose-dependent catch-up growth after 2 years of growth hormone treatment in intrauterine growth-retarded children. J Clin Endocrinol Metab 1994;78:1454–60.

Gee S. The coeliac affection. London: St Bartholomew's3 74: 17. (St Bartholomew's Hospital Report 1888.).

Dossetor JFB Gibson AAM McNeish AS. Childhood coeliac disease is disappearing. Lancet 1981;1:322–3.

Walker-Smith JA Hamilton JR Walker WA. Food related disorders. In: Practical paediatric gastroenterology. London: Butterworth, 1983:213–39.

Groll A Preece MA Candy DC A Tanner JM Harris JT. Short stature as the primary manifestation of coeliac disease. Lancet 1980;ii:1097–9.

Cacciari E Salardi S Volta C Can antigliadin antibody detect symptomless coeliac disease in children with short stature? Lancet 1985;ii:1469–71.

De Luca F Astori M Pandullo E Effects of a gluten-free diet on catch-up growth and height prognosis in coeliac children with growth retardation recognised after the age of 5 years. EurJPediatr 1988;147:188–91.

Cacciari E Salardi S Lazzari R Short stature and celiac disease: A relationship to consider even in patients with no gastrointestinal tract symptoms. J Pediatr 1983; 103:708–11.

Kumar PJ Walker-Smith J Milla P Harris G Colyer J Halliday R. The teenage coeliac: Follow up study of 102 patients. Arch Dis Child 1988;63:916–20.

Blizzard RM Bulatovic A , Psychosocial short stature: A syndrome with many variables. Baillieres Clin Endocrinol Metab 1992;6:687–712.

Talbot NB Sobel EH Burke BS Lindemann E Kaufmann SB. Dwarfism in healthy children: Its possible relation to emotional, nutritional and endocrine disturbances. N Engl J Med 1947;236:783–93.

Patton RG Gardner LI. Influence of family environment on growth: The syndrome of maternal deprivation. Pediatrics 1962;30:957–62.

Rudolf MC Hochberg Z. Are boys more vulnerable to psychosocial growth retardation? Dev Med Child Neurol 1990;32:1022–5.

Money J Annecillo C Kelley JF. Abuse-dwarfism syndrome: After rescue, statural and intellectual catch-up growth correlate. J Clin ChUd Psychol 1983;12:279–83.

Mehls O Blum WF Schaefer F Tonshoff B Scharer K. Growth in renal disease. Baillieres Clin Endocrinol Metab 1992;6:665–85.

Rees L Rigden SPA Ward GM. Chronic renal failure and growth. Arch Dis Child 1989;64:573–7.

Mehls O. Treatment with growth hormone of growth im-pairment in renal disorders. In: Ranke MB Gunnarsson R , eds. Progress in growth hormone therapy – 5years of KIGS. Mannheim: J & J-Verlag, 1994:267–75.

Hagenas L. Bone dysplasias and growth hormone treatment. In: Ranke MB Gunnarsson R , eds. Progress in growth hormone therapy – 5 years of KIGS. Mannheim: J & J-Verlag, 1994:256–65.